Current Issue

Volume: 3 Issue: 1, 12/1/22

Year: 2022

JPharmTech aims to inform all pharmaceutical scientists about the latest and essential research on drug development.

JPharmTech’s primary and future goals are;

  • to have a strong international editorial and advisory board
  • to increase the recognition of the JPharmTech world-wide
  • to be one of the most-cited journals with a high impact factor

JPharmTech publishes two issues per year (June, and December) and primarily accepts original research and review articles covering the formulation, characterization and stability studies of drug delivery systems as well as the latest studies and scientific findings on the products already marketed.

JPharmTech accepts manuscripts from the following areas:

  • Conventional drug delivery systems
  • Novel drug delivery systems
  • Biopharmaceutics
  • Pharmacokinetics
  • Bioavailability & bioequivalence
  • Radiopharmaceuticals
  • Pharmaceutical technology
  • Pharmaceutical nano & biotechnology
  • Cosmetics & cosmeceutical products
  • Nutraceuticals
  • Quality control of dosage forms

Author Information Pack

Before you begin, please read the following explanations.

Authors can download the full JPharmTech Guideline here.


The publication language of the JPharmTech is English. Please perform spell and grammar check of the article. Authors, for whose native language is not English, are strongly encouraged to have their manuscript carefully edited prior to submission. Before submitting, all contributors must agree and sign the Copyright Form. The following three documents must be uploaded for article submission.

  • Copyright Form (form available here)
  • Title Page Document (template available here)
  • Manuscript Body Document (template available here)

All articles should be submitted online, unless otherwise instructed by the editors. Our online submission system guides you stepwise through the process of entering your article details and uploading your files. After the submission, the manuscripts will be edited according to the JPharmTech submission format and authors may be requested for some corrections or for addition of any missing information.

There is no submission or page charges for the JPharmTech.

The main article types are as follows:

Research Articles

The JPharmTech considers all original research articles provided that the work reports scientifically sound experiments and provides a substantial amount of new information. The main text of original articles should be structured according to the “Article Structure” title.

Review Articles

Review articles provide concise and precise updates on the latest progress made in a given area of research. Reviews prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into a high volume of publications with a high citation potential are welcomed.

2021 Journal of Pharmaceutical Technology

Journal of Pharmaceutical Technology Research and Publication Ethics Standards

The articles submitted to JPharmTech are evaluated with plagiarism detection. The articles with an overall similarity score higher than 25% are returned to the author by the editor. Also, if there are big matches with other sources that are included in the bibliography section, the articles are returned to the author by the editor. In some cases, the editor may suggest the author(s) revise their manuscript and submit again. 

Publication Ethics
In an ethically inappropriate situation, action is taken in line with international research and publication ethics. If financial support is received from any institution to conduct the study, the institution that supports the study must be stated in the article.

Research Ethics
In studies where ethics committee approval is required, the name and ethics committee approval number of the institution for which ethics committee approval has been obtained should be specified in the material method section. It should also be added to the material and method section of the article that the protocols and procedures used are ethically reviewed and approved. If the studies requiring an ethics committee report are submitted without it, they will be rejected. Informed consent form must be taken in clinical studies on humans and should be stated in the material method section. All clinical trials should be carried out according to the Helsinki Declaration principles. For animal research, authors should indicate whether the procedures applied comply with the standards set out in the “Guide for the Care and Use of Laboratory Animals” guide. All experimental research on plants should comply with international guidelines.

Copyright Policy
The authors' publications in JPharmTech are distributed under Creative Commons Attribution (CC BY) license ( The license was developed to facilitate open access, namely, free immediate access to and unrestricted reuse of original works of all types. Under this license, authors retain ownership of the copyright for their publications, but grant JPharmTech a non-exclusive license to publish the work in paper form and allow anyone to reuse, distribute and reproduce the content as long as the original work is properly cited. Appropriate attribution can be provided by simply citing the original work. No permission is required from the authors or the publishers. For any reuse or distribution of a work, users must also make clear the license terms under which the work was published. The standard license will be applied to the authors' publications, which ensures the publications freely and openly available in perpetuity.

Open Access Statement
JPharmTech publishes fully open access journal, which means that all articles are available on the internet to all users immediately upon publication. All the original articles and review papers published in JPharmTech are free to access immediately from the date of publication. JPharmTech don’t charge any fees for any reader to download articles and reviews for their own scholarly use. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access. Copyright of the layout and design of JPharmTech articles remains with the journal and cannot be used in other publications. JPharmTech also operates under the Creative Commons Licence CC-BY. All authors publishing with the JPharmTech accept these as the terms of publication.

Processing and publication in Journal of Pharmaceutical Technology are free of charge.

download  download  17117  18771